Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -3 of 3 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 to 80				Other				Panc4242 P01 CA097012, NCT00415454

Last Modified: 12/4/2008 First Published: 11/22/2004


2.		Pilot Study of High-Dose Zidovudine and Valganciclovir, With or Without Bortezomib or R-EPOCH-R (Comprising Etoposide, Doxorubicin, Vincristine, Prednisone, Cyclophosphamide, and Rituximab) or Sirolimus Only or Observation or HAART Only in Patients With Multicentric Castleman's Disease Associated With Kaposi's Sarcoma-Associated Herpesvirus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Active				12 and over				NCI				NCI-04-C-0275 NCT00099073


3.		Efficacy and Safety of Valcyte® as an Add-on Therapy in Patients With Malignant Glioblastoma and CMV Infection

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Supportive care				Active				18 and over				Other				MV20145 Eudra CT: 2006-002022-29, NCT00400322

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute